Prime Medicine, INC DEF 14A proxy statements

Prime Medicine, Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on June 5, 2026, to elect directors and ratify auditor appointment.

Prime Medicine, Inc. is seeking stockholder approval for a one-time repricing of certain outstanding stock options for employees and directors, aiming to restore incentive value following a substantial decline in its common stock price.

Prime Medicine announces a strategic shift focusing on liver diseases and partnered programs, accompanied by a CEO transition and promising early clinical data for its Prime Editing technology.

Prime Medicine, Inc. is holding its 2025 Annual Meeting of Stockholders virtually on June 4, 2025, to vote on the election of directors and ratification of the company's independent auditor.

Prime Medicine will hold its 2025 annual meeting of stockholders virtually on June 4, 2025, to elect directors and ratify the appointment of its independent accounting firm.

Prime Medicine's Board of Directors adopted Second Amended and Restated Bylaws to update corporate governance procedures, including those related to stockholder proposals, director nominations, and meeting protocols.

Prime Medicine, Inc. is holding its 2024 Annual Meeting of Stockholders on June 12, 2024, with voting open until June 11, 2024.

Prime Medicine's upcoming annual meeting on June 12, 2024, will address director elections, officer liability limitations, and accounting firm ratification.